MarkHarrisLeibenhautMD

PubMed

• 17 citations
  Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Tr...
  Christopher U. Jones, Stephanie L. Pugh, Howard M. Sandler, Michael Chetner, Mahul B. Amin, Deborah Watkins Bruner, Anthony L. Zietman, Robert B. Den, Mark H. Leibenha...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Sep 1
• 11 citations
  Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
  R. Charles Nichols, Chen Hu, Jean Paul Bahary, Kenneth L. Zeitzer, Luis Souhami, Mark H. Leibenhaut, Marvin Rotman, Elizabeth Gore, Alexander Balogh, David G. McGowan,...> ;Advances in Radiation Oncology. 2017 Aug 3
• 14 citations
  Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.
  Raymond H. Mak, Daniel Hunt, Jason A. Efstathiou, Niall M. Heney, Christopher U. Jones, Himu Lukka, Jean-Paul Bahary, Malti Patel, Alexander Balogh, Abdenour Nabid, Ma...> ;Urologic Oncology. 2016 Oct 1
• 32 citations
  Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08
  Justin C. Voog, Rebecca Paulus, William U. Shipley, Matthew R. Smith, David G. McGowan, Christopher U. Jones, Jean-Paul Bahary, Kenneth L. Zeitzer, Luis Souhami, Mark ...> ;European Urology. 2016 Feb 1
• 28 citations
  Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408
  Daniel J. Krauss, Chen Hu, Jean Paul Bahary, Luis Souhami, Elizabeth Gore, Susan Chafe, Mark H. Leibenhaut, Samir Narayan, Javier F. Torres-Roca, Jeff M. Michalski, Ke...> ;International Journal of Radiation Oncology, Biology, Physics. 2015 Jul 15
• 541 citations
  Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
  Christopher U. Jones, Daniel P. Hunt, David G. McGowan, Mahul B. Amin, Michael Chetner, Deborah Watkins Bruner, Mark H. Leibenhaut, Siraj Husain, Marvin Rotman, Luis S...> ;The New England Journal of Medicine. 2011 Jul 13
• 71 citations
  Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.
  Andre Konski, Jennifer L. James, William F. Hartsell, Mark H. Leibenhaut, Nora A. Janjan, Walter J. Curran, Mack Roach, Deborah Watkins-Bruner> ;American Journal of Clinical Oncology. 2009 Aug 1
• Radiology Applications of Financial Accounting
  Mark H. Leibenhaut> ;Journal of the American College of Radiology. 2005 Mar 1
• 329 citations
  Survival and Neurologic Outcomes in a Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation Therapy in Brain Metastases
  Minesh P. Mehta, P. Rodrigus, C. Terhaard, Aroor R. Rao, John H. Suh, Wilson Roa, Luis Souhami, Andrea Bezjak, Mark H. Leibenhaut, Ritsuko Komaki, Christopher J. Schul...> ;Journal of Clinical Oncology. 2003 Jul 1
• 121 citations
  Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance im...
  Minesh P. Mehta, William R. Shapiro, Michael Glantz, Roy A. Patchell, Michael A. Weitzner, Christina A. Meyers, Christopher J. Schultz, Wilson H. Roa, Mark H. Leibenha...> ;Journal of Clinical Oncology. 2002 Aug 15
• Management of invasive squamous cell carcinoma of the bulbomembranous male urethra with co-ordinated chemo-radiotherapy and genital preservation.
  Oberfield, R. A., Zinman, L. N., Leibenhaut, M., Girshovich, L., Silverman, M. L.> ;Br J Urol. 1996 Oct
• Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
  Rosenthal, S. A., Linstadt, D. E., Leibenhaut, M. H., Andras, E. J., Brooks, C. P., Stickney, D. R., Chang, G. C., Wolkov, H. B., Gilbert, R. M.> ;Radiology. 1996 May
• The changing role of staging laparotomy in the management of Hodgkin's disease.
  Leibenhaut, M. H.> ;Cancer treatment and research. 1993 Jan 1
• 26 citations
  Intraluminal low-dose rate brachytherapy for malignant endobronchial obstruction.
  Theodore C.M. Lo, John F. Beamis, Robert S. Weinstein, George E. Costey, Charles F. Andrews, David C. Webb-Johnson, Lyubov Girshovich, Mark H. Leibenhaut> ;Radiotherapy and Oncology. 1992 Jan 1
• Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease.
  Leibenhaut, M. H., Hoppe, R. T., Efron, B., Halpern, J., Nelsen, T., Rosenberg, S. A.> ;J Clin Oncol. 1989 Jan
• Role of the spleen in the transdiaphragmatic spread of hodgkin's disease
  Saul A. Rosenberg, Richard T. Hoppe, Mark H. Leibenhaut> ;The American Journal of Medicine. 1987 Aug 1
• 37 citations
  Subdiaphragmatic Hodgkin's disease: laparotomy and treatment results in 49 patients.
  Mark H. Leibenhaut, Richard T. Hoppe, Anna M. Varghese, Saul A. Rosenberg> ;Journal of Clinical Oncology. 1987 Jul 1
• 33 citations
  Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
  David W. Fleming, Mark H. Leibenhaut, Demetrius Albanes, Stephen L. Cochi, Allen W. Hightower, Sue Makintubee, Steven D. Helgerson, Claire V. Broome> ;JAMA. 1985 Jul 26
• Join now to see all